• Navigation
  • Register My DNA Kit
  • Features
  • Pricing
  • FAQ
  • About
  • Labs
  • Login
  • Get started
  1. Home
  2. Genes
  3. RB1

RB1 (RB transcriptional corepressor 1)

Loading...

Summary of RB1

The gene codes for a protein, RB transcriptional corepressor 1. Mutations may cause childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma [R].

0 users want this gene increased, 0 users want it decreased

The Function of RB1

Key regulator of entry into cell division that acts as a tumor suppressor. Promotes G0-G1 transition when phosphorylated by CDK3/cyclin-C. Acts as a transcription repressor of E2F1 target genes. The underphosphorylated, active form of RB1 interacts with E2F1 and represses its transcription activity, leading to cell cycle arrest. Directly involved in heterochromatin formation by maintaining overall chromatin structure and, in particular, that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV39H1, KMT5B and KMT5C, leading to epigenetic transcriptional repression. Controls histone H4 'Lys-20' trimethylation. Inhibits the intrinsic kinase activity of TAF1. Mediates transcriptional repression by SMARCA4/BRG1 by recruiting a histone deacetylase (HDAC) complex to the c-FOS promoter. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex (By similarity). In case of viral infections, interactions with SV40 large T antigen, HPV E7 protein or adenovirus E1A protein induce the disassembly of RB1-E2F1 complex thereby disrupting RB1's activity.

Protein names

Recommended name:

Retinoblastoma-associated protein

Alternative name(s):

p105-Rb
pRb
Rb
pp110

RB1 SNPs

    To see your genotype, you should be logged in and have a file with your genotype uploaded.

  1. RS4151620 (RB1) ??
  2. RS9535020 (RB1) ??

Top Gene-Substance Interactions

RB1 Interacts with These Diseases

Disease Score

Substances That Increase RB1

Substances Interaction Organism Category

Substances That Decrease RB1

Substances Interaction Organism Category

Advanced Summary

     bladder cancer Some gene mutations are acquired during a person's lifetime and are present only in certain cells. These changes, which are called somatic mutations, are not inherited. Somatic mutations that turn off (inactivate) the RB1 gene have been reported in some cases of bladder cancer. Mutations in RB1 are thought to contribute to the development of bladder cancer, and these genetic changes may help predict whether tumors will grow rapidly and spread to other tissues. retinoblastoma Hundreds of mutations in the RB1 gene have been identified in people with retinoblastoma, a rare type of eye cancer that typically affects young children. This cancer develops in the retina, which is the specialized light-sensitive tissue at the back of the eye that detects light and color. Researchers estimate that 40 percent of all retinoblastomas are germinal, which means that RB1 mutations occur in all of the body's cells and can be passed to the next generation. The other 60 percent are non-germinal, which means that RB1 mutations occur only in the eye and cannot be passed to the next generation. In germinal retinoblastoma, an RB1 mutation is present in all of the body's cells. For retinoblastoma to develop, the other copy of the RB1 gene also must be mutated or lost. This second mutation typically occurs early in life in retinal cells. Cells with two altered copies of the RB1 gene produce no functional pRB and are unable to regulate cell division effectively. As a result, retinal cells lacking functional pRB can divide uncontrollably to form cancerous tumors. Some studies suggest that additional genetic changes can influence the development of retinoblastoma; these changes may help explain variations in the development and growth of tumors in different people. In people with germinal retinoblastoma, RB1 mutations increase the risk of several other cancers outside the eye. Specifically, these people are more likely to develop a cancer of the pineal gland in the brain (pinealoma), a type of bone cancer known as osteosarcoma, cancers of soft tissues such as muscle, and an aggressive form of skin cancer called melanoma. Non-germinal retinoblastoma occurs in people with no history of the disorder in their family. Affected individuals are born with two normal copies of the RB1 gene. Then, usually in early childhood, both copies of the gene in retinal cells acquire mutations or are lost. These genetic changes prevent the cells from producing any functional pRB. The loss of this protein allows retinal cells to grow and divide without control or order, leading to the development of a cancerous tumor. other cancers In addition to bladder cancer, somatic mutations in the RB1 gene are associated with many other types of cancer. For example, changes in the RB1 gene have been reported in some cases of lung cancer, breast cancer, a bone cancer known as osteosarcoma, and an aggressive form of skin cancer called melanoma. Somatic RB1 mutations have also been identified in some leukemias, which are cancers of blood-forming cells. Somatic RB1 mutations in cancer cells inactivate pRB so it can no longer regulate cell division effectively.

     The RB1 gene provides instructions for making a protein called pRB. This protein acts as a tumor suppressor, which means that it regulates cell growth and keeps cells from dividing too fast or in an uncontrolled way. Under certain conditions, pRB stops other proteins from triggering DNA replication, the process by which DNA makes a copy of itself. Because DNA replication must occur before a cell can divide, tight regulation of this process controls cell division and helps prevent the growth of tumors. Additionally, pRB interacts with other proteins to influence cell survival, the self-destruction of cells (apoptosis), and the process by which cells mature to carry out special functions (differentiation).

Conditions with Increased Gene Activity

Condition Change (log2fold) Comparison Species Experimental variables Experiment name

Conditions with Decreased Gene Activity

Condition Change (log2fold) Comparison Species Experimental variables Experiment name

Technical

The following transcription factors affect gene expression:

  • p53
  • CREB
  • deltaCREB
  • E2F-1
  • E2F-4
  • YY1

Tissue specificity:

Expressed in the retina.

Gene Pathways:

  • Non-small cell lung cancer
  • Small cell lung cancer
  • Pathways in cancer
  • DNA Replication
  • Bladder cancer
  • Melanoma
  • Prostate cancer
  • Glioma
  • Chronic myeloid leukemia
  • Pancreatic cancer

Molecular Function:

  • Androgen Receptor Binding
  • Core Promoter Binding
  • Dna Binding
  • Kinase Binding
  • Phosphoprotein Binding
  • Transcription Coactivator Activity
  • Transcription Factor Activity, Sequence-Specific Dna Binding
  • Transcription Factor Binding
  • Ubiquitin Protein Ligase Binding
  • Identical Protein Binding

Biological Processes:

  • Androgen Receptor Signaling Pathway
  • Cell Cycle Arrest
  • Cell Cycle Checkpoint
  • Cell Division
  • Cell Morphogenesis Involved In Neuron Differentiation
  • Cellular Response To Xenobiotic Stimulus
  • Covalent Chromatin Modification
  • Chromatin Remodeling
  • Digestive Tract Development
  • Enucleate Erythrocyte Differentiation
  • G1/S Transition Of Mitotic Cell Cycle
  • Glial Cell Apoptotic Process
  • Hepatocyte Apoptotic Process
  • Maintenance Of Mitotic Sister Chromatid Cohesion
  • Mitotic Cell Cycle Checkpoint
  • Myoblast Differentiation
  • Negative Regulation Of Epithelial Cell Proliferation
  • Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle
  • Negative Regulation Of Gene Expression
  • Negative Regulation Of Protein Kinase Activity
  • Negative Regulation Of Sequence-Specific Dna Binding Transcription Factor Activity
  • Negative Regulation Of Smoothened Signaling Pathway
  • Negative Regulation Of Transcription, Dna-Templated
  • Negative Regulation Of Transcription From Rna Polymerase Ii Promoter During Mitotic Cell Cycle
  • Negative Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle
  • Neuron Apoptotic Process
  • Neuron Maturation
  • Neuron Projection Development
  • Positive Regulation Of Macrophage Differentiation
  • Positive Regulation Of Mitotic Metaphase/Anaphase Transition
  • Positive Regulation Of Transcription, Dna-Templated
  • Positive Regulation Of Transcription From Rna Polymerase Ii Promoter
  • Positive Regulation Of Transcription Regulatory Region Dna Binding
  • Protein Localization To Chromosome, Centromeric Region
  • Ras Protein Signal Transduction
  • Regulation Of Cell Growth
  • Regulation Of Centromere Complex Assembly
  • Regulation Of Cohesin Loading
  • Regulation Of Lipid Kinase Activity
  • Regulation Of Mitotic Cell Cycle
  • Regulation Of Transcription Involved In G1/S Transition Of Mitotic Cell Cycle
  • Sister Chromatid Biorientation
  • Skeletal Muscle Cell Differentiation
  • Striated Muscle Cell Differentiation
  • Tissue Homeostasis
  • Transcription, Dna-Templated
  • Viral Process

Drug Bank:

  • Insulin Regular
*synonyms

Synonyms/Aliases/Alternative Names of the Gene:

hypothetical protein| rb| A306_03614| AS27_04781| AS28_07935| D623_10026554| exon 17 tumor GOS561 substitution mutation causes premature stop| GOS563 exon 17 substitution mutation causes premature stop| H920_10734| I79_013349| M91_14938| M959_05381| MDA_GLEAN10007375| N300_11918| N301_11492| N303_10248| N305_02003| N306_06166| N307_11235| N308_12951| N309_15111| N310_06537| N311_06035| N320_00567| N322_04865| N325_00623| N326_01706| N329_02039| N330_13955| N331_11648| N332_03867| N333_11664| N334_03045| N336_02034| N340_02440| N341_13071| OSRC| p104| p105-Rb| PAL_GLEAN10021709| pp105| PP110| PPP1R130| pRB| prepro-retinoblastoma-associated protein| protein phosphatase 1, regulatory subunit 130| Rb-1| RB11| retinoblastoma| retinoblastoma 1| Retinoblastoma 1 (including osteosarcoma)| Retinoblastoma-associated protein| retinoblastoma protein| retinoblastoma protein 1| retinoblastoma, susceptibility| retinoblastoma susceptibility protein| retinoblastoma suspectibility protein| retinoblastoma tumor suppressor| spc| TREES_T100006162| UY3_10497| XRb1| Y1Q_005312| Y956_16115| Z169_05991| rb1

Policies

  • Terms of Service
  • Platform Consent
  • Privacy Policy
  • Disclaimer

About

  • Customer Support
  • Our Team
  • Affiliate Program

Navigation

  • Homepage
  • DNA Wellness Reports
  • Personalized Genetics Blog
  • Register your DNA Test Kit
  • Login
  • Careers
GET STARTED
  • SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode does not treat, diagnose or cure any conditions, but is for informational and educational purposes alone.
SelfDecode © 2021 All Rights Reserved